E-LIB Suche - Ergebnisse für: Facchin, S

1

OC.03.12: SODIUM BUTYRATE SUPPLEMENTATION SIGNIFICANTLY IMP..:

Facchin, S. ; Calgaro, M. ; Pandolfo, M....
Digestive and Liver Disease. 56 (2024) - p. S140-S141 , 2024

Link: https://doi.org/10.1016/..

2

P859 Sodium Butyrate supplementation significantly improved..:

Facchin, S ; Calgaro, M ; Pandolfo, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1590-i1591 , 2024

Link: https://doi.org/10.1093/..

3

Tissue culture technology for sumac (Rhus coriaria) propaga..:

Leto, Leandra ; Facchin, S.L ; Micheli, M..
Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 157 (2023) 4 - p. 881-889 , 2023

Link: https://doi.org/10.1080/..

4

T.04.7 A SPECIFIC MICROBIOTA SIGNATURE IS ASSOCIATED TO VAR..:

Barberio, B. ; Facchin, S. ; Patuzzi, I....
Digestive and Liver Disease. 54 (2022) - p. S131 , 2022

Link: https://doi.org/10.1016/..

5

P295 Comparative Assessment of Infliximab Trough Levels bet..:

Maniero, D ; Lorenzon, G ; Marsilio, I...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S325-S325 , 2021

Link: https://doi.org/10.1093/..

6

P329 Comparative Assessment of Adalimumab Trough Levels bet..:

Marsilio, I ; Maniero, D ; Lorenzon, G...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S353-S353 , 2021

Link: https://doi.org/10.1093/..

7

AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BE..:

Marsilio, I. ; Maniero, D. ; Lorenzon, G....
Digestive and Liver Disease. 53 (2021) - p. S158 , 2021

Link: https://doi.org/10.1016/..

8

AF.56 COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BE..:

Maniero, D. ; Lorenzon, G. ; Marsilio, I....
Digestive and Liver Disease. 53 (2021) - p. S162 , 2021

Link: https://doi.org/10.1016/..

9

T04.01.21 INTESTINAL MICROBIOTA CHANGES ACCORDING TO DISEAS..:

Barberio, B. ; Bertazzo, E. ; Marinelli, C....
Digestive and Liver Disease. 52 (2020) - p. S126 , 2020

Link: https://doi.org/10.1016/..

10

P.07.28 PREVIOUS EXPOSURE TO INFLIXIMAB INDUCES CROSS-REACT..:

Facchin, S. ; Agbariah, N. ; Buda, A....
Digestive and Liver Disease. 51 (2019) - p. e234 , 2019

Link: https://doi.org/10.1016/..

11

P.07.2 DISEASE ACTIVITY INFLUENCES DISABILITY AND QUALITY O..:

Marinelli, C. ; Savarino, E. ; Inferrera, M....
Digestive and Liver Disease. 51 (2019) - p. e221-e222 , 2019

Link: https://doi.org/10.1016/..

12

P655 Microencapsulated Sodium Butyrate significantly modifi..:

Facchin, S ; Vitulo, N ; Perini, B...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S446-S447 , 2019

Link: https://doi.org/10.1093/..

13

OC.12.4 RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB A..:

Facchin, S. ; Buda, A. ; Cardin, R....
Digestive and Liver Disease. 51 (2019) - p. e110-e111 , 2019

Link: https://doi.org/10.1016/..

14

OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DIS..:

Buda, A. ; Facchin, S. ; Lorenzon, G....
Digestive and Liver Disease. 51 (2019) - p. e101 , 2019

Link: https://doi.org/10.1016/..

15

N18 Mood disorders in a IBD population: a single-centre coh..:

Lorenzon, G ; Dessì, A ; Marinelli, C...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S565-S565 , 2019

Link: https://doi.org/10.1093/..